An inhibitor of CTL A-4 lymphocyte domain used to treat melanoma (PMID 23714523). Reviews on management of AE at PMID 23772560, 24278787. Incidence of ILD higher if ipilumab and nivolumab are given concomitantly (PMID 25891304)

Last update : 05/05/2018
I - Interstitial/parenchymal lung disease
II - Pulmonary edema - Acute lung injury - ARDS
V - Pleural and/or pericardial involvement
VII - Mediastinal involvement
IX - Neuromuscular / CNS involvement - Disordered breathing during sleep
X - Systemic/Distant conditions, syndromes and reactions
XII - Cardiovascular involvement / toxicity
XV - Pathology
XVI - Imaging
XVII - Infections & related conditions
XIX - Cytological, biochemical features of/in BAL, pleural fluid or FNA